Category Archives: Featured

COVID-19: In Maryland and across America, disparate outcomes show impacts of inequities

By on .

Allison Agwu, M.D., ScM is an associate professor of Adult and Pediatric Infectious Diseases at Johns Hopkins University School of Medicine in Baltimore, Maryland. She cares for patients across the age spectrum, in both the pediatric and adult Ryan-White funded HIV clinics at Johns Hopkins, as the founder and medical director of the Accessing Care […]

COVID-19: In Amb. Birx, the White House gets a scientist, physician, public health expert and global health realist as response coordinator

By on .

If the criteria for the selection announced Wednesday night of Vice President Mike Pence to lead the U.S. efforts to contain the spread of COVID-19 seemed less than obvious to public health experts, another appointment announced today may bring a measure of reassurance. Mr. Pence faced criticism in his most prominent previous role in a […]

IDWeek: Ending HIV as an epidemic will demand innovation, inclusion, an expanded workforce — and funding

By on .

As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades into an epidemic that has taken the lives more than 700,000 people in America, still close to 40,000 people in this country are diagnosed with HIV here each year. […]

When viral suppression didn’t last, lowering barriers to HIV treatment and care made a difference

By on .

The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. If 90 percent of all people living with the virus knew it, 90 percent of them access antiretroviral treatment, and 90 percent of those on treatment — that is […]

IAS 2019: With new data, WHO updates DTG guidelines including women in strong, preferred recommendation

By on .

MEXICO CITY – Responding to expanded data gathered in Botswana and Brazil, and to input from communities of women living with HIV, the World Health Organization announced updated guidelines for the use of dolutegravir, restoring the agency’s recommendation that the antiretroviral medicine with fewer side effects, lower resistance, and quicker viral suppression than alternatives is […]

Communication was Dr. Manasseh Phiri’s prescription for infectious diseases

By on .

Dr. Manasseh Phiri was working at the Centre for Infectious Disease Research in Zambia when I met him 10 years ago, although his days as a practicing physician were well behind him by then. Dispirited by the unrelenting toll of AIDS in his country over the decades before life-saving treatment made it there, when locals […]

With promise to “eliminate the HIV epidemic,” and “defeat AIDS in America and beyond,” administration raises questions about policies

By on .

While plan will target 48 “hot spots” with services, and people at high risks with PrEP, will it change policies that fuel HIV? More details are available today on plans to “eliminate the HIV epidemic,” announced by the president in his State of the Union address last night, and while they raise new questions as […]

PEPFAR partners reveal HIV prevention service cuts from expanded “Mexico City Policy,” as organizations endorse act to end its restrictions

By on .

“Protecting Life in Global Health Assistance” policy, also known as the Global Gag Rule, is hitting services for young women the hardest, survey finds When the Trump administration State Department began to enforce a newly reinstated, and greatly expanded version of the restrictions on health information provided by U.S.-funded overseas organizations known as the “Mexico […]

Senate extends PEPFAR, while funding remains a question

By on .

With a matter-of-fact and unanimous approval of the PEPFAR Extension Act of 2018, a five-year renewal of the U.S. flagship program to combat HIV globally, the U.S. Senate Wednesday evening showed that what was once considered revolutionary, can now be considered routine. Perceptions that efforts to stop the spread of an incurable virus across countries […]

Dolutegravir results in low-resource setting highlight benefits

By on .

A standard of care treatment in high-income settings, the benefits of dolutegravir-based treatments for HIV have been clear, with a built-in barrier to the development of drug-resistance, and a less frequent or severe side effects that interfere with staying on a medicine. But the benefits in low-income countries have been harder to assess, with costs, […]